| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5892011 | Bone | 2011 | 9 Pages |
Abstract
⺠Nilotinib inhibits osteoblast proliferation and differentiation. ⺠Nilotinib inhibits osteoclastogenesis. ⺠Patients taking nilotinib have low bone turnover and secondary hyperparathyroidism. ⺠Prospective studies of the skeletal effects of nilotinib should be undertaken.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Susannah O'Sullivan, Jian-Ming Lin, Maureen Watson, Karen Callon, Pak Cheung Tong, Dorit Naot, Anne Horne, Opetaia Aati, Fran Porteous, Greg Gamble, Jillian Cornish, Peter Browett, Andrew Grey,